Trump's Populist 'America First' Should Scare American Jews and Worry Israelis

Topping Estimates, Teva Reports $5.1 Billion Q3 Revenue

A day after CEO steps down, company reports 2% increase in sales, with U.S. generics revenues up 6%.

A day after its CEO Jeremy Levin was ousted by the board, Teva Pharmaceuticals reported third-quarter earnings on Thursday that...